Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose U Scher

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
The Journal of Rheumatology|March 3, 2015
Intestinal dysbiosis and potential consequences of microbiome-altering antibiotic use in the pathogenesis of human rheumatic diseaseJose U Scher
Cleveland Clinic Journal of Medicine|March 15, 2016
The microbiome in celiac disease: Beyond diet-genetic interactionsJose U Scher
Current Opinion in Rheumatology|October 17, 2017
The 2018 landscape of RA, PsA, and SpA pathogenesisJose U Scher
Bulletin of the NYU Hospital for Joint Diseases|December 25, 2012
B-cell therapies for rheumatoid arthritisJose U Scher
Bulletin of the Hospital for Joint Disease (2013)|October 25, 2013
Monotherapy in rheumatoid arthritisJose U Scher
The Journal of Rheumatology. Supplement|June 3, 2018
The Microbiome in Psoriasis and Psoriatic Arthritis: JointsJose U Scher
The Lancet. Rheumatology|January 22, 2024
Prevention of psoriatic arthritis: the next frontierAlexis Ogdie, Jose U Scher
Current Rheumatology Reports|September 15, 2014
Biomarkers in psoriatic arthritis: recent progressVinod Chandran, Jose U Scher
Clinical Immunology (Orlando, Fla.)|June 1, 2020
Not your average joint: Towards precision medicine in psoriatic arthritisRochelle Castillo, Jose U Scher
Current Rheumatology Reports|December 9, 2019
Strategies to Improve Outcomes in Psoriatic ArthritisChristopher Ritchlin, Jose U Scher
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
The Journal of Rheumatology|March 3, 2015
Intestinal dysbiosis and potential consequences of microbiome-altering antibiotic use in the pathogenesis of human rheumatic diseaseJose U Scher
Cleveland Clinic Journal of Medicine|March 15, 2016
The microbiome in celiac disease: Beyond diet-genetic interactionsJose U Scher
Current Opinion in Rheumatology|October 17, 2017
The 2018 landscape of RA, PsA, and SpA pathogenesisJose U Scher
Bulletin of the NYU Hospital for Joint Diseases|December 25, 2012
B-cell therapies for rheumatoid arthritisJose U Scher
Bulletin of the Hospital for Joint Disease (2013)|October 25, 2013
Monotherapy in rheumatoid arthritisJose U Scher
The Journal of Rheumatology. Supplement|June 3, 2018
The Microbiome in Psoriasis and Psoriatic Arthritis: JointsJose U Scher
The Lancet. Rheumatology|January 22, 2024
Prevention of psoriatic arthritis: the next frontierAlexis Ogdie, Jose U Scher
Current Rheumatology Reports|September 15, 2014
Biomarkers in psoriatic arthritis: recent progressVinod Chandran, Jose U Scher
Clinical Immunology (Orlando, Fla.)|June 1, 2020
Not your average joint: Towards precision medicine in psoriatic arthritisRochelle Castillo, Jose U Scher
Current Rheumatology Reports|December 9, 2019
Strategies to Improve Outcomes in Psoriatic ArthritisChristopher Ritchlin, Jose U Scher
Pageof 16